2.09p+0.04 (+1.95%)17 Jun 2024, 09:24
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo

Shield Therapeutics PLC Market & Company News

28.05.2024 20:32GAL, ORCP, BMVTRADING UPDATES: NetScientific backs Wanda; Inspirit Energy wins dealAlliance
28.05.2024 07:00STXNew Drug Application for Accrufer® in South KoreaRNS
23.05.2024 07:15STXHardman & Co: Shield Therapeutics (STX): Cash management is keyEQS
10.05.2024 15:30STXAudited results for the year ended 31 Dec 2023RNS
30.04.2024 19:54TAND, IGE, CHLEARNINGS AND TRADING: Software Circle & Beximco report higher revenueAlliance
30.04.2024 07:00STXBusiness Update for Q1 2024RNS
23.04.2024 14:26WTB, ROR, SAFEUK earnings, trading statements calendar - next 7 daysAlliance
16.04.2024 07:00STXNotice of ResultsRNS
21.02.2024 12:36STXShield Therapeutics sinks as strong performance marred by data issuesAlliance
21.02.2024 07:00STXUnaudited Full Year Trading UpdateRNS
09.01.2024 11:33STXIN BRIEF: Shield Therapeutics hires former Akili leader as new CFOAlliance
09.01.2024 07:00STXAppointment of new Chief Financial OfficerRNS
07.12.2023 15:31COM, IGP, WSPTRADING UPDATES: Comptoir opens restaurant; Intercede wins contractAlliance
07.12.2023 07:00STXQ3 2023 U.S. Commercial HighlightsRNS
27.11.2023 17:24STXPDMR Transaction NotificationRNS
15.11.2023 07:30STXHardman & Co Research on Shield Therapeutics (STX): Accelerating effectiveness of enlarged sales teamEQS
20.10.2023 11:45STXAbstract to be presented at Healthcare ConferenceReach
12.10.2023 11:14STXIN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leaveAlliance
12.10.2023 10:27WNWD, NBB, STXAIM WINNERS & LOSERS: Windward sees high contracting activity levelsAlliance
12.10.2023 07:00STXChief Financial Officer TransitionRNS
03.10.2023 17:14STX, CLIG, ALKTRADING UPDATES: Aston Martin CEO ups stake; Alkemy's lithium dealAlliance
03.10.2023 15:00STXResult of REX Retail OfferRNS
03.10.2023 14:29STXShield Therapeutics completes USD20 million SWK financingAlliance
03.10.2023 07:00STXBlock listing Interim ReturnRNS
03.10.2023 07:00STXCompletion of SWK FinancingRNS
28.09.2023 14:54STXUPDATE: Shield Therapeutics completes GBP5 million share placing Alliance
28.09.2023 12:50STXSuccessful completion of US$6.1m Equity FundraiseRNS
28.09.2023 11:30STXShield Therapeutics raises funds for US sales push as loss narrowsAlliance
28.09.2023 07:02STXREX Retail OfferRNS
28.09.2023 07:01STX$20m secured debt facility &proposed equity raiseRNS
28.09.2023 07:00STXInterim results update and business updateRNS
21.09.2023 15:48XLM, TRIN, TRLSUK earnings, trading statements calendar - next 7 daysAlliance
06.09.2023 20:33STXIN BRIEF: Shield Therapeutics changes reporting currency to US dollarsAlliance
06.09.2023 07:00STXNotice of Results and Change in reporting currencyRNS
25.07.2023 09:45STXHardman & Co Research on Shield Therapeutics (STX): Accrufer Rx momentum gatheringEQS
24.07.2023 14:27JUP, STXHolding(s) in CompanyRNS
20.07.2023 11:43STXIN BRIEF: Shield Therapeutics prescription orders up in first quarterAlliance
20.07.2023 07:00STXBusiness Update and U.S. Q2 2023 HighlightsRNS
28.06.2023 17:30STXResults of 2023 Annual General MeetingRNS
21.06.2023 15:43ZED, WSG, W7LUK shareholder meetings calendar - next 7 daysAlliance
16.06.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
15.06.2023 16:35STXLapse of OfferRNS
15.06.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
15.06.2023 07:00STXAcceptance Level UpdateRNS
14.06.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
14.06.2023 07:00STXAcceptance Level UpdateRNS
13.06.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
13.06.2023 07:00STXAcceptance Level UpdateRNS
12.06.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
12.06.2023 07:00STXAcceptance Level UpdateRNS
09.06.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
09.06.2023 07:00STXAcceptance Level UpdateRNS
08.06.2023 12:31STXForm 8.3 - Shield Therapeutics PLC (amendment)RNS
08.06.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
08.06.2023 07:00STXAcceptance Level UpdateRNS
07.06.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
06.06.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
06.06.2023 10:10STXGrant of share options to the CEORNS
05.06.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
02.06.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
01.06.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
01.06.2023 11:00STXHolding(s) in CompanyRNS
01.06.2023 10:55STXHolding(s) in CompanyRNS
31.05.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
31.05.2023 07:00STXTotal Voting RightsRNS
30.05.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
26.05.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
25.05.2023 16:44STXPublication and posting of Offer DocumentRNS
25.05.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
24.05.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
23.05.2023 12:00STXForm 8.5 (EPT/RI) - Shield Therapeutics PlcRNS
22.05.2023 13:25STXForm 8.3 - Shield Therapeutics PLCRNS
19.05.2023 16:17STXForm 8.3 - Shield Therapeutics PlcRNS
19.05.2023 14:29STXForm 8.3 – Shield Therapeutics plcRNS
18.05.2023 15:15STXForm 8 (OPD) - Shield Therapeutics plcRNS
Showing 1 to 75 of 265